Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 "PembroRad" randomized trial

被引：51
|
作者：
Bourhis, J. [1 ]
Sire, C. [2 ]
Tao, Y. [3 ]
Martin, L. [4 ]
Alfonsi, M. [5 ]
Prevost, J. B. [6 ]
Rives, M. [7 ]
Lafond, C. [8 ]
Tourani, J. M. [9 ]
Biau, J. [10 ]
Geoffrois, L. [11 ]
Coutte, A. [12 ]
Liem, X. [13 ]
Vauleon, E. [14 ]
Drouet, F. [15 ]
Pechery, A. [16 ]
Guigay, J. [17 ]
Wanneveich, M. [16 ]
Auperin, A. [3 ]
Sun, X. [18 ]
机构：
[1] CHU Vaudois, Radiat Oncol, Lausanne, Switzerland
[2] CHU Bretagne Sud, Lorient, France
[3] Inst Gustave Roussy, Radiat Oncol, Villejuif, France
[4] Clin Ormeaux, Le Havre, France
[5] Inst St Catherine, Avignon, France
[6] Ctr Pierre Curie, Beuvry, France
[7] Inst Claudius Regaud, Toulouse, France
[8] Clin Victor Hugo, Le Mans, France
[9] CHU Poitiers, Hop Jean Bernard, Poitiers, France
[10] Ctr Lutte Canc J Perrin, Clermont Ferrand, France
[11] Inst Cancerol Lorraine Alexis Vautrin, Med Oncol, Vandoeuvre Les Nancy, France
[12] CHU Amiens Picardie Site Sud, Radiat Oncol, Amiens, France
[13] Ctr Oscar Lambret, Radiotherapy, Lille, France
[14] Ctr Eugene Marquis, Rennes, France
[15] Clin Mutualiste Estuaire, St Nazaire, France
[16] CHU Bretonneau, GORTEC, Tours, France
[17] Ctr Anticanc Antoine Lacassagne, Med Oncol Dept, Nice, France
[18] Hop Nord Franche Comte, Belfort, France
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.2268
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA38
引用
收藏
页码：S1168 / S1168
页数：1
相关论文
共 50 条
  • [31] Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial
    Tao, Yungan
    Auperin, Anne
    Sire, Christian
    Martin, Laurent
    Khoury, Cedric
    Maingon, Philippe
    Bardet, Etienne
    Kaminsky, Marie-Christine
    Lapeyre, Michel
    Chatellier, Thierry
    Alfonsi, Marc
    Pointreau, Yoann
    Jadaud, Eric
    Gery, Bernard
    Zawadi, Ayman
    Tourani, Jean-Marc
    Laguerre, Brigitte
    Coutte, Alexandre
    Racadot, Severine
    Hasbini, Ali
    Malaurie, Emanuelle
    Borel, Christian
    Meert, Nicolas
    Cornely, Alexandre
    Ollivier, Nathalie
    Casiraghi, Odile
    Sun, Xu Shan
    Bourhis, Jean
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (31) : 3084 - +
  • [32] Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)'
    Hanemaaijer, S. H.
    Kok, I. C.
    Fehrmann, R. S. N.
    van der Vegt, B.
    Gietema, J. A.
    Plaat, B. E. C.
    Vugt, M. A. T. M.
    Vergeer, M. R.
    Voortman, J.
    Leemans, C. R.
    Buter, J.
    Langendijk, J. A.
    Oosting, S. F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] Avelumab-cetuximab-radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)
    Tao, Yungan
    Auperin, Anne
    Sun, Xushan
    Sire, Christian
    Martin, Laurent
    Coutte, Alexandre
    Lafond, Cedrik
    Miroir, Jessica
    Liem, Xavier
    Rolland, Frederic
    Even, Caroline
    Nguyen, France
    Saada, Esma
    Maillard, Aline
    Colin-Batailhou, Natacha
    Thariat, Juliette
    Guigay, Joel
    Bourhis, Jean
    EUROPEAN JOURNAL OF CANCER, 2020, 141 : 21 - 29
  • [34] Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial
    Bonomo, Pierluigi
    Desideri, Isacco
    Mangoni, Monica
    Saieva, Calogero
    Loi, Mauro
    Becherini, Carlotta
    Cerbai, Cecilia
    Ganovelli, Michele
    Salvestrini, Viola
    Stocchi, Giulia
    Zani, Margherita
    Palomba, Annarita
    Livi, Lorenzo
    RADIOTHERAPY AND ONCOLOGY, 2022, 169 : 64 - 70
  • [35] Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase I/II trial
    Bonomo, P.
    Desideri, I.
    Mangoni, M.
    Loi, M.
    Saieva, C.
    Marrazzo, L.
    Talamonti, C.
    Salvatore, G.
    Sottili, M.
    Teriaca, M. A.
    Stocchi, G.
    Cerbai, C.
    Salvestrini, V.
    Ganovelli, M.
    Massi, D.
    Gallo, O.
    Santoro, R.
    Spinelli, G.
    Pallotta, S.
    Livi, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S686 - S686
  • [36] Phase II randomized trial of radiotherapy (RT), cetuximab (E), and pemetrexed (Pem) with or without bevacizumab (B) in locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Kotsakis, A. P.
    Heron, D. E.
    Kubicek, G. J.
    Ferris, R. L.
    Kim, S.
    Gibson, M. K.
    Duvvuri, U.
    Grandis, J. R.
    Johnson, J. T.
    Argiris, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Phase II randomized trial of radiotherapy (RT), cetuximab (E), and pemetrexed (Pem) with or without bevacizumab (B) in locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Argiris, Athanassios
    Ohr, James
    Kubicek, Greg J.
    Duvvuri, Uma
    Heron, Dwight Earl
    Kotsakis, Athanasios Panayotis
    Spencer, Christina
    Kim, Seungwon
    Grandis, Jennifer R.
    Johnson, Jonas Talmadge
    Bauman, Julie E.
    Gibson, Michael K.
    Ferris, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Phase 3 study of Pembrolizumab plus Chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): KEYNOTE-412
    Machiels, Jean-Pascal
    Yen, Chia-Jui
    Licitra, Lisa
    Rischin, Danny
    Waldron, John
    Burtness, Barbara
    Gregoire, Vincent
    Agarwala, Sanjiv
    Tao, Yun Gan
    Yorio, Jeffrey
    Aksoy, Sercan
    Ikeda, Sadakatsu
    Hong, Ruey-Long
    Ge, Joy Yang
    Brown, Holly
    Bidadi, Behzad
    Siu, Lillian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [39] Nimotuzumab in combination with intensity modulated radiotherapy improve survival in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A multicenterbased real-world study
    Yi, Junlin
    Lang, Jin Yi
    Zhang, Chenping
    Zhang, Xin-Xin
    Wu, Shao-xiong
    Sun, Yan
    Wang, Peiguo
    Qiu, Sufang
    Huang, Xiaodong
    Zhang, Peng
    Ren, Guoxin
    Liu, Kun
    Du, Xiao-Jing
    Xiao, Shaowen
    Wang, Zhong Qiu
    Weng, Youliang
    Zhang, Ye
    Zhou, Hang
    Tu, Wenyong
    Bai, Xianhong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Factors associated with hospitalization in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA-HNSCC) treated with definitive chemoradiation (CRT).
    Park, Soo J.
    Parikh, Mili
    Harrington, Joanne
    Heppner, Pia
    McCarthy, Kelly
    Crandall, Bailey
    Wong-Sefidan, Ida
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345